Dyfyniad APA

Joglekar, T., Lin, J., & Shibata, M. (2020). ONECUT2 is a novel target for treatment of castration-resistant prostate cancer. Expert Opin Ther Targets.

Dyfyniad Arddull Chicago

Joglekar, Tejashree, Jianqing Lin, and Maho Shibata. "ONECUT2 Is a Novel Target for Treatment of Castration-resistant Prostate Cancer." Expert Opin Ther Targets 2020.

Dyfyniad MLA

Joglekar, Tejashree, Jianqing Lin, and Maho Shibata. "ONECUT2 Is a Novel Target for Treatment of Castration-resistant Prostate Cancer." Expert Opin Ther Targets 2020.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.